In December 2014 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4069 (the Athlete) after his sample tested positive for the prohibited substance tulobuterol. After notification a provisional suspension was ordered and the Athlete filed a statement in his defence.
The Athlete submitted, sustained by his doctor and medical record, that he suffered from asthma and had used Hokunalin medication which was prescribed for the treatment of his son’s bronchitis.
The Athlete took the medication a few days before the competition as an emergency measure due to his aggravating asthma before he received medical treatment in the hospital by his family doctor.
The Panel accepts the Athlete’s statement and concludes that he was carelessly with the use of the Hokunalin medication as emergency measure. Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 30 January 2015 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 17 December 2014.
